Number of IND applications of innovative drugs submitted in China 2018-2021
An Investigational New Drug (IND) is a drug or biopharmaceutical product that is not yet approved for general use by the regulatory body while being used in clinical trials to examine its efficacy and safety. An IND application is the prerequisite for a drug product to enter its clinical trial phase.